Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-related lupus.

E V Hess1

  • 1University of Cincinnati Medical Sciences Center, Ohio.

Current Opinion in Rheumatology
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Physicians should be aware of drug-related lupus, an autoimmune condition triggered by various medications, including new biologic treatments. Understanding the immune responses and genetic factors involved is crucial for managing this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The immune profile of human seminal plasma.

Immunology today·2014
Same author

Importance of drugs and environmental agents in Lupus.

Lupus·2007
Same author

Women in rheumatology.

The Journal of rheumatology·2001
Same author

Approaches for identifying and defining environmentally associated rheumatic disorders.

Arthritis and rheumatism·2000
Same author

Are there environmental forms of systemic autoimmune diseases?

Environmental health perspectives·1999
Same author

North American undergraduate education in rheumatology.

The Journal of rheumatology. Supplement·1999
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Area of Science:

  • Immunology
  • Pharmacology
  • Rheumatology

Background:

  • Drug-related lupus is an autoimmune syndrome associated with numerous medications.
  • Increasing reports highlight immune responses and antibodies linked to drug-induced lupus.
  • New biologic treatments are a growing concern for potentially inducing autoimmune phenomena.

Purpose of the Study:

  • To alert physicians to the increasing prevalence of drug-related lupus.
  • To review the diverse immune responses and antibodies associated with this syndrome.
  • To explore the mechanisms underlying drug-induced autoimmune conditions.

Main Methods:

  • Review of existing literature on drug-related lupus.
  • Analysis of immune responses to drugs, metabolites, and conjugates.

Related Experiment Videos

  • Investigation of bioactivation, macrophage roles, and drug acetylation in immunogenetics.

    • Main Results:

    • A wide spectrum of immune responses and antibodies are implicated in drug-related lupus.
    • Environmental factors and drug metabolism pathways offer insights into disease mechanisms.
    • Drug acetylation and immunogenetic factors play a significant role.

    Conclusions:

    • Drug-related lupus is an important clinical consideration for physicians.
    • Further research into environmental factors and immune mechanisms is necessary.
    • Studying drug-induced lupus can illuminate the pathogenesis of systemic lupus erythematosus.